These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 32909933

  • 1. MexXY RND pump of Pseudomonas aeruginosa PA7 effluxes bi-anionic β-lactams carbenicillin and sulbenicillin when it partners with the outer membrane factor OprA but not with OprM.
    Singh M, Sykes EME, Li Y, Kumar A.
    Microbiology (Reading); 2020 Nov; 166(11):1095-1106. PubMed ID: 32909933
    [Abstract] [Full Text] [Related]

  • 2. Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7.
    Morita Y, Tomida J, Kawamura Y.
    Microbiology (Reading); 2012 Apr; 158(Pt 4):1071-1083. PubMed ID: 22282519
    [Abstract] [Full Text] [Related]

  • 3. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa.
    Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T.
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3322-7. PubMed ID: 11083635
    [Abstract] [Full Text] [Related]

  • 4. Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Vettoretti L, Plésiat P, Muller C, El Garch F, Phan G, Attrée I, Ducruix A, Llanes C.
    Antimicrob Agents Chemother; 2009 May; 53(5):1987-97. PubMed ID: 19258280
    [Abstract] [Full Text] [Related]

  • 5. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.
    Dean CR, Visalli MA, Projan SJ, Sum PE, Bradford PA.
    Antimicrob Agents Chemother; 2003 Mar; 47(3):972-8. PubMed ID: 12604529
    [Abstract] [Full Text] [Related]

  • 6. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
    Goli HR, Nahaei MR, Rezaee MA, Hasani A, Kafil HS, Aghazadeh M, Nikbakht M, Khalili Y.
    J Infect Public Health; 2018 Mar; 11(3):364-372. PubMed ID: 28993173
    [Abstract] [Full Text] [Related]

  • 7. Expression of RND efflux pumps mediated antibiotic resistance in Pseudomonas aeruginosa clinical strains.
    Zahedi Bialvaei A, Rahbar M, Hamidi-Farahani R, Asgari A, Esmailkhani A, Mardani Dashti Y, Soleiman-Meigooni S.
    Microb Pathog; 2021 Apr; 153():104789. PubMed ID: 33556480
    [Abstract] [Full Text] [Related]

  • 8. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
    Goli HR, Nahaei MR, Rezaee MA, Hasani A, Samadi Kafil H, Aghazadeh M, Sheikhalizadeh V.
    Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
    [Abstract] [Full Text] [Related]

  • 9. Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system.
    Poole K, Gilmour C, Farha MA, Parkins MD, Klinoski R, Brown ED.
    J Antimicrob Chemother; 2018 May 01; 73(5):1247-1255. PubMed ID: 29420743
    [Abstract] [Full Text] [Related]

  • 10. Knock-out of multidrug efflux pump MexXY-OprM results in increased susceptibility to antimicrobial peptides in Pseudomonas aeruginosa.
    Neidig A, Strempel N, Waeber NB, Nizer WSDC, Overhage J.
    Microbiol Immunol; 2023 Sep 01; 67(9):422-427. PubMed ID: 37424105
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
    Pan YP, Xu YH, Wang ZX, Fang YP, Shen JL.
    Arch Microbiol; 2016 Aug 01; 198(6):565-71. PubMed ID: 27060003
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin.
    Hocquet D, Roussel-Delvallez M, Cavallo JD, Plésiat P.
    Antimicrob Agents Chemother; 2007 Apr 01; 51(4):1582-3. PubMed ID: 17220417
    [No Abstract] [Full Text] [Related]

  • 19. Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa.
    Middlemiss JK, Poole K.
    J Bacteriol; 2004 Mar 01; 186(5):1258-69. PubMed ID: 14973037
    [Abstract] [Full Text] [Related]

  • 20. Fmt bypass in Pseudomonas aeruginosa causes induction of MexXY efflux pump expression.
    Caughlan RE, Sriram S, Daigle DM, Woods AL, Buco J, Peterson RL, Dzink-Fox J, Walker S, Dean CR.
    Antimicrob Agents Chemother; 2009 Dec 01; 53(12):5015-21. PubMed ID: 19786597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.